Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccine
On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an…
COVID-19 | Disease | HIV | Measles | Medicine | Pharmaceutical | Therapeutics | Vaccine
Resilience collaborated with Children’s Hospital of Philadelphia to develop next-gen biomanufacturing technologies
On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…
Merck and Ridgeback announced Submission of EUA to the FDA for Molnupiravir, an Investigational Oral antiviral medicine, for treatment of COVID-19
On Oct. 11, 2021, Merck and Ridgeback Biotherapeutics announced that Merck had submitted an Emergency Use Authorization (EUA)…
Washington University School of Medicine reported antiviral compound blocked SARS-CoV-2 from entering cells
On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…
INOVIO expanded INNOVATE phase 3 for INO-4800 to include Colombia
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
U.S. CDC reported more than 140,000 U.S. children lost a primary or secondary caregiver due to COVID-19 pandemic
On Oct. 7, 2021, the Centers for Disease Control and Prevention (CDC) reported One U.S. child loses a…
PerkinElmer received FDA Emergency Use Authorization for respiratory SARS-CoV-2 panel
On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) had issued Emergency Use…
Duke University-led study showed Vaxart’s oral COVID-19 vaccine candidate reduced transmission of SARS-CoV-2 infection
On Oct. 7, 2021, Vaxart announced that a Duke University-led study published in bioRxiv showed that Vaxart’s (investigational…
Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year
On Oct. 7, 2021, Moderna announced it was building a state-of-the-art mRNA facility in Africa with the goal…
USDA confirmed COVID-19 infection in a Binturong and a Fishing Cat at an Illinois Zoo
On Oct. 6, 2021, the U.S. Department of Agriculture’s Agriculture Research Service (ARS) announced confirmation of SARS-CoV-2 (the…
Vaxartﾠbegan recruiting in global phase II COVID-19 oral tablet vaccine clinical trial
On Oct. 6, 2021, Vaxart announced that it had begun recruiting subjects for its Phase II COVID-19 oral…
AIM ImmunoTech published phase 1 clinical study data supporting the safety of Ampligen as intranasal therapy
On Oct. 6, 2021, AIM ImmunoTech released detailed safety data from a Phase 1 clinical study which supported…
Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launched
On Oct. 6, 2021, Washington University School of Medicine announced the start of a pediatric COVID-19 vaccine clinical…
Vaccination linked reduction of over a quarter million COVID-19 cases, 100,000 hospitalizations, and 39,000 deaths among seniors
On Oct. 5, 2021, a new report from the U.S. Department of Health and Human Services (HHS) showed…
COVID-19 | Diagnostics | FDA
EUROIMMUN anti-SARS-CoV-2 S1 curve ELISA received FDA Emergency Use Authorization
On Oct. 5, 2021, PerkinElmer announced that the U.S. Food and Drug Administration had provided Emergency Use Authorization…
Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and older
On Oct. 5, 2021, Moderna announced that the European Medicines Agency (EMA) had authorized a third dose of…
Johnson & Johnson submitted EUA amendment to FDA to support booster of single-shot COVID-19 vaccine
On Oct. 5, 2021, Johnson & Johnson announced it had submitted data to the U.S. Food and Drug…
ACON’s Flowflexﾙ COVID-19 home test received FDA EUA
On Oct. 4, 2021, ACON Laboratories announced that its Flowflexﾙ COVID-19 Antigen Home Test had been authorized for…
Pfizer and BioNTech received CHMP positive opinion for COVID-19 vaccine booster in the European Union
On Oct. 4, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
Labcorp received EUA for at home collection kit for combined COVID-19 and flu detection
On Oct. 1, 2021, LabCorp announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…
Merck and Ridgeback’s oral antiviral reduced risk of hospitalization or death for patients with COVID-19 in positive phase 3 study
On Oct. 1, 2021, Merck and Ridgeback Biotherapeutics announced that molnupiravir (MK-4482, EIDD-2801), an investigational oral antiviral medicine,…
Humanigen submitted all planned modules forpotential conditional Marketing Authorization from UKﾒs MHRA
On Oct. 1, 2021, Humanigen announced it had submitted all the planned modules as well as a risk…
Relief reported that collaboration partner announced a second favorable safety report for ZYESAMI(TM) in Patients with COVID-19
On Sept. 30, 2021, RELIEF THERAPEUTICS reported that the parent company of its U.S. collaboration partner, NRx Pharmaceuticals,…
Fifteen African countries hit 10% COVID-19 vaccination goal
On Sept. 30, 2021, the WHO announced that fifteen African countries – nearly a third of the continent’s…
Trevena announced results of TRV027 proof-of-concept study in COVID-19 patients
On Sept. 30, 2021, Trevena announced data from 30 patients enrolled in the proof-of-concept study of TRV027, the…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Medical Device | Neurology | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 vaccinated vs. non-vaccinated
This cartoon illustrates the various issues facing individuals across the U.S. who are vaccinated against COVID-19 verus those…
2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin Karik
On Sept. 29, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…
Pfizer reported positive top-line results of phase 3 study exploring coadministration of Prevnar 20 With seasonal Flu vaccine
On Sept. 29, 2021, Pfizer and BioNTech announced they had submitted data to the U.S. Food and Drug…
NEJM published positive phase 3 trial resulted for REGEN-COV (casirivimab and imdevimab) to treat COVID-19
On Sept. 29, 2021, Regeneron announced that the New England Journal of Medicine (NEJM) published positive detailed results…
VBI Vaccines announced preclinical data and Initiation of VBI-2905 clinical trial targeting broadened immunity against COVID-19
On Sept. 29, 2021, VBI Vaccines announced positive results from multiple preclinical studies against several COVID-19 variants of…